维普中文期刊产品整合服务
71篇 您的检索式:作者名="Witton"
    题名 作者 年代 出处 被引量
1A typical features in pleomorphic adenoma clinicopathologic study and implications for management显示文摘Ethunandan M Witton R Hoffman G el al 2006Int J Oral Maxillofae Surg2006,35,7:1
2AKT activation predicts outcome in breast cancer patients treated with tamoxifen显示文摘Kirkegaard T Witton CJ McGlynn LM 2005J Pathol2005,207,2:1
3Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer显示文摘WITTON C J REEVES J R GOING J J 0,,03:1
4Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer 显示文摘Tovey S Dunne B Witton GJ 2005Clin Cancer Res2005,11,12:1
5Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling 显示文摘Tovey SM Witton CJ Bartlett JM 2004Breast Cancer Res2004,6,3:1
6AKT activation predicts outcome in breast cancer patients treated with tamoxifen显示文摘Kirkegaard T Witton CJ McGlynn LM 0,,02:1
7Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer显示文摘Witton CJ Reeves JR Going JJ 2003J Pathol2003,200,:1
8Gene amplifications associated with the development of honnone-resistant prostate cancer 显示文摘Edwards J Krishna NS Witton CJ 2003Clin Cancer Res2003,9,14:1
9Phenothiazines and sudden death显示文摘Witton K 1965JAMA1965,,194:1
10Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer显示文摘Witton C J Reeves JR Going JJ 2003J Patbol2003,200,3:1
11Expression of the HER1 -4 family of receptor tyrosine kinases in breast canc-er显示文摘Witton CJ Reeves JR Going J J 2003J Pathol2003,200,3:1
12Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer?显示文摘TOVEY S DUNNE B WITTON C J 2005Clin Cancer Res2005,11,13:1
13Atypical features in pleomorphic adenoma-a clinicopathologic study and implications for management显示文摘Ethunandan M Witton R Hoffman G 2006Int J Oral Maxillofac Surg2006,35,:1
14Outcome and human epidermal growth factor receptor(HER) 1 -4 status in inva-sire breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling显示文摘Tovey SM Witton CJ Bartlett JM 2004Breast Cancer Res2004,6,3:1
15Cyclooxygenase-2 (COX2) expression is associated with poor outcome in ER-negative,but not ER-positive, breast cancer 显示文摘 Hawe SJ Cooke TG 2004Histopathology2004,45,1:1
16HER4 in breast cancer:comparison of antibodies against intra-and extra-cellular domains of HER4显示文摘Tovey SM Dunne B Witton CJ 2006Breast Cancer Res2006,8,2:1
17Molecular alteration in Akt1,Akt2 and Akt3 detected in breast and prostatic cancer by FISH显示文摘KIRKEGAARD T WITTON C J EDWARDS J 2010Histopathology2010,56,2:1
18HER4 in breast cancer:comparison of anti-bodies against intra-and extra-cellular domains of HER4显示文摘Tovey SM Dunne B Witton CJ 2006Breast Cancer Research2006,8,2:1
19Expression of the HER1-4 family of receptor tyrosine kinases in breast Cancer显示文摘Witton CJ Reeves JR Going JJ 0,,03:1
20Gene amplifications associated with the development of hormone-resistant prostate cancer显示文摘Edwards J Krishna N S Witton C J 2003Clin Cancer Res2003,9,14:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费